The obesity drug market is red-hot thanks to the huge success of Novo Nordisk's (NYSE: NVO) Ozempic and Wegovy. On ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE